These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37878637)

  • 1. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
    Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
    PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
    Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
    HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era.
    Pabo WLRT; Njume D; Ndip RN; Takou D; Santoro MM; Chenwi C; Beloumou G; Semengue ENJ; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Nyasa RB; Anguechia DHG; Kamta C; Bala L; Lambo V; Sosso SM; Colizzi V; Perno CF; Fokam J; Ndjolo A
    J Public Health Afr; 2023 Oct; 14(10):2612. PubMed ID: 38020274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.
    Adawaye C; Fokam J; Kamangu E; Alio HM; Chahad AM; Susin F; Moussa AM; Bertin TH; Tidjani A; Vaira D; Moutschen M
    BMC Res Notes; 2017 Nov; 10(1):589. PubMed ID: 29126456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
    Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
    Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
    Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
    Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
    BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near full genome characterization of HIV-1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns.
    Banin AN; Tuen M; Bimela JS; Tongo M; Zappile P; Khodadadi-Jamayran A; Nanfack AJ; Okonko IO; Meli J; Wang X; Mbanya D; Ngogang J; Gorny MK; Heguy A; Fokunang C; Duerr R
    J Int AIDS Soc; 2019 Jul; 22(7):e25362. PubMed ID: 31353798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
    Sudjaritruk T; Teeraananchai S; Kariminia A; Lapphra K; Kumarasamy N; Fong MS; Hansudewechakul R; Bunupuradah T; Ly PS; Nallusamy RA; Sohn AH; Sirisanthana V;
    J Int AIDS Soc; 2020 Jul; 23(7):e25550. PubMed ID: 32628816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
    Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
    Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
    Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
    HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
    Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
    J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon.
    Fokam J; Salpini R; Santoro MM; Cento V; Perno CF; Colizzi V; Ndumbe PM; Fokunang Ntungen C; Ndiang Tetang SM; Nanfack AJ; Takou Komego DA; Cappelli G
    Pediatr Infect Dis J; 2011 Dec; 30(12):1062-8. PubMed ID: 21817951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
    Penda CI; Moukoko Mbonjo M; Fokam J; Djeuda ABD; Grace N; Ateba Ndongo F; Bilong S; Eyoum Bille B; Koki Ndombo P; Aghokeng A; Ndjolo A; Eboumbou Moukoko CE
    PLoS One; 2022; 17(10):e0276730. PubMed ID: 36288365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
    Santoro MM; Alteri C; Ronga L; Flandre P; Fabeni L; Mercurio F; D'Arrigo R; Gori C; Palamara G; Bertoli A; Forbici F; Salpini R; Boumis E; Tozzi V; Visco-Comandini U; Zaccarelli M; Van Houtte M; Pattery T; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1285-93. PubMed ID: 22417570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.
    Fokam J; Billong SC; Jogue F; Moyo Tetang Ndiang S; Nga Motaze AC; Paul KN; Njom Nlend AE
    PLoS One; 2017; 12(11):e0187566. PubMed ID: 29112991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.